Therapeutic potential of flavonoids in inflammatory bowel Disease: A comprehensive review

World Journal of Gastroenterology

Volumn 23, Issue 28, 2017, Pages 5097-5114

  Salaritabar, Ali ^a   Darvishi, Behrad ^a   HadjiakhoonDi, Farzaneh ^b   Manayi, Azadeh ^b   Sureda, Antoni ^c   Nabavi, Seyed Fazel ^d   Fitzpatrick, Leo R ^e   Nabavi, Seyed Mohammad ^d   Bishayee, Anupam ^f  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e CALIFORNIA NORTHSTATE UNIVERSITY   (United States)

^f Larkin University   (United States)

Author keywords

Antioxidant; Flavonoids; Gastrointestinal tract; Inflammation; Polyphenols

Indexed keywords

APIGENIN; AURANTIIN; BAICALEIN; CATECHIN; CYANIDIN; DAIDZEIN; DELPHINIDIN; DIOSMIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONOID; GALLOCATECHIN; GENISTEIN; HESPERETIN; HESPERIDIN; KAEMPFEROL; LUTEOLIN; MALVIDIN CHLORIDE; MORIN; NARINGENIN; PELARGONIDIN; PETUNIDIN; QUERCETIN; QUERCITRIN; RUTOSIDE; SILYMARIN; TANGERETIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; WOGONIN; ANTIINFLAMMATORY AGENT;

ACETIC ACID INDUCED COLITIS; ACETIC ACID-INDUCED COLITIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BARBERRY; BERBERIDACEAE; BILBERRY; BLUEBERRY; CRANBERRY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TOLERABILITY; EXPERIMENTAL COLITIS; GRAPE; HUMAN; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PHASEOLUS VULGARIS; REVIEW; STRAWBERRY; TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS; ULCERATIVE COLITIS; ANIMAL; CLINICAL TRIAL (TOPIC); COLON; CROHN DISEASE; DISEASE MODEL; DRUG EFFECT; INTESTINE MUCOSA; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DISEASE MODELS, ANIMAL; FLAVONOIDS; INTESTINAL MUCOSA; TREATMENT OUTCOME;

EID: 85026530097     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i28.5097     Document Type: Review

References (172)

1. Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 2012; 32: 261-286 [PMID: 22404118 DO I: 10.1146/annurev-nutr-071811-150623]
2. Cicchitti L, Martelli M, Cerritelli F. Chronic inflammatory disease and osteopathy: a systematic review. PLoS One 2015; 10: e0121327 [PMID: 25781621 DO I: 10.1371/journal.pone.0121327]
3. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci 1997; 2: d12-d26 [PMID: 9159205]
4. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996; 1317: 84-94 [PMID: 8950192 DO I: 10.1016/S0925-4439(96)00048-8]
5. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866 [PMID: 10602461 DO I: 10.1038/sj.onc.1203239]
6. Katori M, Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000; 49: 367-392 [PMID: 11028754 DO I: 10.1007/s000110050605]
7. Fitzpatrick LR. Novel Pharmacological Approaches for Inflammatory Bowel disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis. Int J Inflam 2012; 2012: 389404 [PMID: 22506136 DO I: 10.1155/2012/389404]
8. Wéra O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel diseases. J Clin Med 2016; 5: pii: E118 [PMID: 27999328 DO I: 10.3390/jcm5120118]
9. Corridoni D, Arseneau KO, Cominelli F. Inflammatory bowel disease. Immunol Lett 2014; 161: 231-235 [PMID: 24938525 DO I: 10.1016/j.imlet.2014.04.004]
10. Deepak P, Loftus EV Jr. Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy. Drug Des Devel Ther 2016; 10: 3685-3698 [PMID: 27956825 DO I: 10.2147/DD T.S102141]
11. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995; 332: 292-297 [PMID: 7816064 DO I: 10.1056/NEJM199502023320503]
12. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30 [PMID: 22001864 DO I: 10.1053/j.gastro.2011.10.001]
13. Winkel-Shirley B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 2001; 126: 485-493 [PMID: 11402179 DO I: 10.1104/pp.126.2.485]
14. de Lange DW, Verhoef S, Gorter G, Kraaijenhagen RJ, van de Wiel A, Akkerman JW. Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. Alcohol Clin Exp Res 2007; 31: 1308-1314 [PMID: 17559545 DO I: 10.1111/j.1530-0277.2007.00439.x]
15. Rosenkranz S, Knirel D, dietrich H, Flesch M, Erdmann E, Böhm M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox". FASEB J 2002; 16: 1958-1960 [PMID: 12397093 DO I: 10.1096/fj.02-0207fje]
16. Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33: 1061-1080 [PMID: 8847003 DO I: 10.1016/0278-6915(95)00077-1]
17. Burr ML. Explaining the French paradox. J R Soc Health 1995; 115: 217-219 [PMID: 7562866 DOI: 10.1177/1466424095115004 04]
18. Alvesalo J, Vuorela H, Tammela P, Leinonen M, Saikku P, Vuorela P. Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures. Biochem Pharmacol 2006; 71: 735-741 [PMID: 16414027 DO I: 10.1016/j.bcp.2005.12.006]
19. Subarnas A, Wagner H. Analgesic and anti-inflammatory activity of the proanthocyanidin shellegueain A from Polypodium feei METT. Phytomedicine 2000; 7: 401-405 [PMID: 11081991 DO I: 10.1016/S0944-7113(00)80061-6]
20. Calderone V, Chericoni S, Martinelli C, Testai L, Nardi A, Morelli I, Breschi MC, Martinotti E. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 290-298 [PMID: 15378228 DO I: 10.1007/s00210-004-0964-z]
21. Calixto JB, Campos MM, Otuki MF, Santos AR. Antiinflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004; 70: 93-103 [PMID: 14994184 DO I: 10.1055/s-2004-815483]
22. García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009; 58: 537-552 [PMID: 19381780 DO I: 10.1007/s00011-009-0037-3]
23. Lu MF, Xiao ZT, Zhang HY. Where do health benefits of flavonoids come from? Insights from flavonoid targets and their evolutionary history. Biochem Biophys Res Commun 2013; 434: 701-704 [PMID: 23624504 DO I: 10.1016/j.bbrc.2013.04.035]
24. Duda-Chodak A, Tarko T, Satora P, Sroka P. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur J Nutr 2015; 54: 325-341 [PMID: 25672526 DO I: 10.1007/s00394-015-0852-y]
25. Parkar SG, Trower TM, Stevenson DE. Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. Anaerobe 2013; 23: 12-19 [PMID: 23916722 DO I: 10.1016/j.anaerobe.2013.07.009]
26. Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 2013; 24: 1415-1422 [PMID: 23849454 DO I: 10.1016/j.jnutbio.2013.05.001]
27. Vezza T, Rodríguez-Nogales A, Algieri F, Utrilla MP, Rodriguez-Cabezas ME, Galvez J. Flavonoids in Inflammatory Bowel disease: A Review. Nutrients 2016; 8: 211 [PMID: 27070642 DO I: 10.3390/nu8040211]
28. Aherne SA, O'Brien NM. dietary flavonols: chemistry, food content, and metabolism. Nutrition 2002; 18: 75-81 [PMID: 11827770 DO I: 10.1016/S0899-9007(01)00695-5]
29. Kwon KH, Murakami A, Tanaka T, Ohigashi H. dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of proinflammatory gene expression. Biochem Pharmacol 2005; 69: 395-406 [PMID: 15652231 DO I: 10.1016/j.bcp.2004.10.015]
30. Guazelli CF, Fattori V, Colombo BB, Georgetti SR, Vicentini FT, Casagrande R, Baracat MM, Verri WA Jr. Quercetin-loaded microcapsules ameliorate experimental colitis in mice by antiinflammatory and antioxidant mechanisms. J Nat Prod 2013; 76: 200-208 [PMID: 23347547 DO I: 10.1021/np300670w]
31. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, Zarzuelo A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through downregulation of the NF-kappaB pathway. Eur J Immunol 2005; 35: 584-592 [PMID: 15668926 DO I: 10.1002/eji.200425778]
32. Caddeo C, Nácher A, díez-Sales O, Merino-Sanjuán M, Fadda AM, Manconi M. Chitosan-xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin. J Microencapsul 2014; 31: 694-699 [PMID: 24903450 DO I: 10.310 9/02652048.2014.913726]
33. Crespy V, Morand C, Besson C, Manach C, Demigne C, Remesy C. Quercetin, but not its glycosides, is absorbed from the rat stomach. J Agric Food Chem 2002; 50: 618-621 [PMID: 11804539 DO I: 10.1021/jf010919h]
34. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727-747 [PMID: 15113710]
35. Crespy V, Morand C, Manach C, Besson C, Demigne C, Remesy C. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 1999; 277: G120-G126 [PMID: 10409158]
36. Macdonald IA, Mader JA, Bussard RG. The role of rutin and quercitrin in stimulating flavonol glycosidase activity by cultured cell-free microbial preparations of human feces and saliva. Mutat Res 1983; 122: 95-102 [PMID: 6419088 DO I: 10.1016/0165-7992( 83)90044-1]
37. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995; 62: 1276-1282 [PMID: 7491892]
38. van der Sluis AA, Dekker M, Jongen WM. Flavonoids as bioactive components in apple products. Cancer Lett 1997; 114: 107-108 [PMID: 9103266 DO I: 10.1016/S0304-3835(97)04637-5]
39. Hollman PC, Bijsman MN, van Gameren Y, Cnossen EP, de Vries JH, Katan MB. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 1999; 31: 569-573 [PMID: 10630681 DO I: 10.1080/10715769900 301141]
40. Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ, Neckers L, Jung Y. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res 2005; 22: 1499-1509 [PMID: 16132362 DO I: 10.1007/s11095-005-6250-z]
41. Castangia I, Nácher A, Caddeo C, Merino V, díez-Sales O, Catalán-Latorre A, Fernàndez-Busquets X, Fadda AM, Manconi M. Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats. Acta Biomater 2015; 13: 216-227 [PMID: 25463498 DO I: 10.1016/j.actbio.2014.11.017]
42. Dodda D, Chhajed R, Mishra J, Padhy M. Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin. Indian J Pharmacol 2014; 46: 286-291 [PMID: 24987175 DO I: 10.4103/0253-7613.132160]
43. Dodda D, Chhajed R, Mishra J. Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: possible morphological and biochemical alterations. Pharmacol Rep 2014; 66: 169-173 [PMID: 24905324 DO I: 10.1016/j.pharep.2013.08.013]
44. Sánchez de Medina F, Gálvez J, Romero JA, Zarzuelo A. Effect of quercitrin on acute and chronic experimental colitis in the rat. J Pharmacol Exp Ther 1996; 278: 771-779 [PMID: 8768730]
45. Cruz T, Gálvez J, Ocete MA, Crespo ME, Sánchez de Medina L-H F, Zarzuelo A. Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci 1998; 62: 687-695 [PMID: 9472728 DO I: 10.1016/S0024-3205(97)01164-8]
46. Camuesco D, Comalada M, Rodríguez-Cabezas ME, Nieto A, Lorente MD, Concha A, Zarzuelo A, Gálvez J. The intestinal antiinflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 2004; 143: 908-918 [PMID: 15533892 DO I: 10.1038/sj.bjp.0705941]
47. Liu SH, Lu TH, Su CC, Lay IS, Lin HY, Fang KM, Ho TJ, Chen KL, Su YC, Chiang WC, Chen YW. Lotus leaf (Nelumbo nucifera) and its active constituents prevent inflammatory responses in macrophages via JNK/NF-B signaling pathway. Am J Chin Med 2014; 42: 869-889 [PMID: 25004880 DO I: 10.1142/S0192415X14500554]
48. Kim BH, Cho SM, Reddy AM, Kim YS, Min KR, Kim Y. Down-regulatory effect of quercitrin gallate on nuclear factorkappa B-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7. Biochem Pharmacol 2005; 69: 1577-1583 [PMID: 15896337 DO I: 10.1016/j.bcp.2005.03.014]
49. Mascaraque C, Aranda C, Ocón B, Monte MJ, Suárez MD, Zarzuelo A, Marín JJ, Martínez-Augustin O, de Medina FS. Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis. Pharmacol Res 2014; 90: 48-57 [PMID: 25281414 DO I: 10.1016/j.phrs.2014.09.005]
50. Caselli A, Cirri P, Santi A, Paoli P. Morin: A Promising Natural Drug. Curr Med Chem 2016; 23: 774-791 [PMID: 26018232 DO I: 10.2174/0929867323666160106150821]
51. Dhanasekar C, Kalaiselvan S, Rasool M. Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-B Activation. PLoS One 2015; 10: e0145093 [PMID: 26709520 DO I: 10.1371/journal.pone.0145093]
52. Ocete MA, Gálvez J, Crespo ME, Cruz T, González M, Torres MI, Zarzuelo A. Effects of morin on an experimental model of acute colitis in rats. Pharmacology 1998; 57: 261-270 [PMID: 9742291 DO I: 10.1159/000028250]
53. Gálvez J, Coelho G, Crespo ME, Cruz T, Rodríguez-Cabezas ME, Concha A, Gonzalez M, Zarzuelo A. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment Pharmacol Ther 2001; 15: 2027-2039 [PMID: 11736735 DO I: 10.1046/j.1365-2036.2001.01133.x]
54. Devi KP, Malar DS, Nabavi SF, Sureda A, Xiao J, Nabavi SM, Daglia M. Kaempferol and inflammation: From chemistry to medicine. Pharmacol Res 2015; 99: 1-10 [PMID: 25982933 DO I: 10.1016/j.phrs.2015.05.002]
55. Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 2011; 11: 298-344 [PMID: 21428901 DO I: 10.2174/138955711795305335]
56. Lee J, Kim JH. Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro. PLoS One 2016; 11: e0155264 [PMID: 27175782 DO I: 10.1371/journal.pone.0155264]
57. Lee GA, Choi KC, Hwang KA. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environ Toxicol Pharmacol 2017; 49: 48-57 [PMID: 27902959 DO I: 10.1016/j.etap.2016.11.016]
58. Kim SH, Hwang KA, Choi KC. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J Nutr Biochem 2016; 28: 70-82 [PMID: 26878784 DO I: 10.1016/j.jnutbio.2015.09.027]
59. Song H, Bao J, Wei Y, Chen Y, Mao X, Li J, Yang Z, Xue Y. Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study. Oncol Rep 2015; 33: 868-874 [PMID: 25500692 DO I: 10.3892/or.2014.3662]
60. Dang Q, Song W, Xu D, Ma Y, Li F, Zeng J, Zhu G, Wang X, Chang LS, He D, Li L. Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis. Mol Carcinog 2015; 54: 831-840 [PMID: 24700700 DO I: 10.1002/mc.22154]
61. Kim SH, Choi KC. Anti-cancer Effect and Underlying Mechanism(s) of Kaempferol, a Phytoestrogen, on the Regulation of Apoptosis in diverse Cancer Cell Models. Toxicol Res 2013; 29: 229-234 [PMID: 24578792 DO I: 10.5487/TR.2013.29.4.229]
62. Tatsimo SJ, Tamokou Jde D, Havyarimana L, Csupor D, Forgo P, Hohmann J, Kuiate JR, Tane P. Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum. BMC Res Notes 2012; 5: 158 [PMID: 22433844 DO I: 10.1186/1756-0500-5-158]
63. Bloor SJ. An antimicrobial kaempferol-diacyl-rhamnoside from Pentachondra pumila. Phytochemistry 1995; 38: 1033-1035 [PMID: 7766385 DO I: 10.1016/0031-9422(94)00661-C]
64. Huang YB, Lin MW, Chao Y, Huang CT, Tsai YH, Wu PC. Antioxidant activity and attenuation of bladder hyperactivity by the flavonoid compound kaempferol. Int J Urol 2014; 21: 94-98 [PMID: 23634640 DO I: 10.1111/iju.12179]
65. Nirmala P, Ramanathan M. Effect of kaempferol on lipid peroxidation and antioxidant status in 1,2-dimethyl hydrazine induced colorectal carcinoma in rats. Eur J Pharmacol 2011; 654: 75-79 [PMID: 21172346 DO I: 10.1016/j.ejphar.2010.11.034]
66. Kampkötter A, Gombitang Nkwonkam C, Zurawski RF, Timpel C, Chovolou Y, Wätjen W, Kahl R. Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans. Arch Toxicol 2007; 81: 849-858 [PMID: 17551714 DO I: 10.1007/s00204-007-0215-4]
67. Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ. distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem 2006; 54: 9798-9804 [PMID: 17177504 DO I: 10.1021/jf0620719]
68. Sanz MJ, Ferrandiz ML, Cejudo M, Terencio MC, Gil B, Bustos G, Ubeda A, Gunasegaran R, Alcaraz MJ. Influence of a series of natural flavonoids on free radical generating systems and oxidative stress. Xenobiotica 1994; 24: 689-699 [PMID: 7975732 DO I: 10.3109/00498259409043270]
69. Parveen Z, Deng Y, Saeed MK, Dai R, Ahamad W, Yu YH. Antiinflammatory and analgesic activities of Thesium chinense Turcz extracts and its major flavonoids, kaempferol and kaempferol-3-O-glucoside. Yakugaku Zasshi 2007; 127: 1275-1279 [PMID: 17666881 DO I: 10.1248/yakushi.127.1275]
70. Goel RK, Pandey VB, Dwivedi SP, Rao YV. Antiinflammatory and antiulcer effects of kaempferol, a flavone, isolated from Rhamnus procumbens. Indian J Exp Biol 1988; 26: 121-124 [PMID: 3294164]
71. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007; 2007: 45673 [PMID: 18274639 DO I: 10.1155/2007/45673]
72. Park MY, Ji GE, Sung MK. dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice. dig dis Sci 2012; 57: 355-363 [PMID: 21901258 DO I: 10.1007/s10620-011-1883-8]
73. Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM, Aggarwal BB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med 2010; 76: 1044-1063 [PMID: 20635307 DO I: 10.1055/s-0030-1250111]
74. Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites 2015; 5: 56-73 [PMID: 25594250 DO I: 10.3390/metabo5010056]
75. Ko KP. Isoflavones: chemistry, analysis, functions and effects on health and cancer. Asian Pac J Cancer Prev 2014; 15: 7001-7010 [PMID: 25227781 DO I: 10.7314/APJCP.2014.15.17.7001]
76. Sepehr E, Cooke GM, Robertson P, Gilani GS. Effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged male rats. Mol Nutr Food Res 2009; 53 Suppl 1: S16-S26 [PMID: 19437481 DO I: 10.1002/mnfr.200800170]
77. Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat Res Biol 2010; 8: 89-98 [PMID: 20235891 DO I: 10.1089/lrb.2009.0030]
78. Marzocchella L, Fantini M, Benvenuto M, Masuelli L, Tresoldi I, Modesti A, Bei R. dietary flavonoids: molecular mechanisms of action as anti-inflammatory agents. Recent Pat Inflamm Allergy Drug discov 2011; 5: 200-220 [PMID: 21827399 DO I: 10.2174/18 7221311797264937]
79. Braniste V, Leveque M, Buisson-Brenac C, Bueno L, Fioramonti J, Houdeau E. Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol 2009; 587: 3317-3328 [PMID: 19433574 DO I: 10.1113/jphysiol.2009.169300]
80. Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Lencina C, Lévêque M, Braniste V, Ménard S, Théodorou V, Houdeau E. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PLoS One 2012; 7: e49547 [PMID: 23166707 DO I: 10.1371/journal.pone.0049547]
81. Choi S, Woo JK, Jang YS, Kang JH, Jang JE, Yi TH, Park SY, Kim SY, Yoon YS, Oh SH. Fermented Pueraria Lobata extract ameliorates dextran sulfate sodium-induced colitis by reducing proinflammatory cytokines and recovering intestinal barrier function. Lab Anim Res 2016; 32: 151-159 [PMID: 27729931 DO I: 10.5625/lar.2016.32.3.151]
82. Satsu H, Hyun JS, Shin HS, Shimizu M. Suppressive effect of an isoflavone fraction on tumor necrosis factor-alpha-induced interleukin-8 production in human intestinal epithelial Caco-2 cells. J Nutr Sci Vitaminol (Tokyo) 2009; 55: 442-446 [PMID: 19926933 DO I: 10.3177/jnsv.55.442]
83. Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, diel P. Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr 2009; 48: 213-220 [PMID: 19234664 DO I: 10.1007/s00394-009-0004-3]
84. Harnish DC, Albert LM, Leathurby Y, Eckert AM, Ciarletta A, Kasaian M, Keith JC Jr. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2004; 286: G118-G125 [PMID: 12958017 DO I: 10.1152/ajpgi.00024.2003]
85. Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC Jr. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003; 144: 4241-4249 [PMID: 14500559 DO I: 10.1210/en.2003-0550]
86. Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, Degen GH, diel P. In utero and postnatal exposure to a phytoestrogen-enriched diet increases parameters of acute inflammation in a rat model of TNBS-induced colitis. Arch Toxicol 2008; 82: 941-950 [PMID: 18504553 DO I: 10.1007/s00204-008-0309-7]
87. Rao RK, Basuroy S, Rao VU, Karnaky Jr KJ, Gupta A. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherinbeta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002; 368: 471-481 [PMID: 12169098 DO I: 10.1042/bj20011804]
88. Atkinson KJ, Rao RK. Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1280-G1288 [PMID: 11352822]
89. Suzuki T, Hara H. Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J Nutr 2009; 139: 965-974 [PMID: 19297429 DO I: 10.3945/jn.108.100867]
90. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, Bode H, Epple HJ, Riecken EO, Schulzke JD. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999; 112: 137-146 [PMID: 9841910]
91. Sergent T, Piront N, Meurice J, Toussaint O, Schneider YJ. Antiinflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem Biol Interact 2010; 188: 659-667 [PMID: 20816778 DO I: 10.1016/j.cbi.2010.08.007]
92. Ji G, Zhang Y, Yang Q, Cheng S, Hao J, Zhao X, Jiang Z. Genistein suppresses LPS-induced inflammatory response through inhibiting NF-B following AMP kinase activation in RAW 264.7 macrophages. PLoS One 2012; 7: e53101 [PMID: 23300870 DO I: 10.1371/journal.pone.0053101]
93. Morimoto M, Watanabe T, Yamori M, Takebe M, Wakatsuki Y. Isoflavones regulate innate immunity and inhibit experimental colitis. J Gastroenterol Hepatol 2009; 24: 1123-1129 [PMID: 19220665 DO I: 10.1111/j.1440-1746.2008.05714.x]
94. Sakai T, Furoku S, Nakamoto M, Shuto E, Hosaka T, Nishioka Y, Sone S. Soy isoflavone equol perpetuates dextran sulfate sodiuminduced acute colitis in mice. Biosci Biotechnol Biochem 2011; 75: 593-595 [PMID: 21389602 DO I: 10.1271/bbb.100710]
95. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-956 [PMID: 8743980 DO I: 10.1016/0891-5849(95)02227-9]
96. Li C, Schluesener H. Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr 2017; 57: 613-631 [PMID: 25675136 DO I: 10.1080/10408398.2014.906382]
97. Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007; 61: 472-477 [PMID: 17047689]
98. Rani N, Bharti S, Krishnamurthy B, Bhatia J, Sharma C, Kamal MA, Ojha S, Arya DS. Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise. Curr Pharm Des 2016; 22: 4341-4359 [PMID: 27238365 DO I: 10.2174/1381612822666160530150936]
99. Mir IA, Tiku AB. Chemopreventive and therapeutic potential of "naringenin," a flavanone present in citrus fruits. Nutr Cancer 2015; 67: 27-42 [PMID: 25514618 DO I: 10.1080/01635581.2015. 976320]
100. Kumar VS, Rajmane AR, Adil M, Kandhare AD, Ghosh P, Bodhankar SL. Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats. J Biomed Res 2014; 28: 132-145 [PMID: 24683411]
101. Dou W, Zhang J, Sun A, Zhang E, ding L, Mukherjee S, Wei X, Chou G, Wang ZT, Mani S. Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-B signalling. Br J Nutr 2013; 110: 599-608 [PMID: 23506745 DO I: 10.1017/S0007114512005594]
102. Azuma T, Shigeshiro M, Kodama M, Tanabe S, Suzuki T. Supplement naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr 2013; 143: 827-834 [PMID: 23596159 DO I: 10.3945/jn.113.174508]
103. Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, Al-Assaf AH, Parmar MY, Ahmed MM. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol 2013; 19: 5633-5644 [PMID: 24039355 DO I: 10.3748/wjg.v19.i34.5633]
104. Xu L, Yang ZL, Li P, Zhou YQ. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine 2009; 16: 989-995 [PMID: 19386481 DO I: 10.1016/j.phymed.2009.02.021]
105. Prior RL, Wu X. Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res 2006; 40: 1014-1028 [PMID: 17015246 DO I: 10.1080/1 0715760600758522]
106. Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 2010; 31: 446-467 [PMID: 20854839 DO I: 10.1016/j.mam.2010.09.007]
107. Shin DY, Lee WS, Kim SH, Kim MJ, Yun JW, Lu JN, Lee SJ, Tsoy I, Kim HJ, Ryu CH, Kim GY, Kang HS, Shin SC, Choi YH. Anti-invasive activity of anthocyanins isolated from Vitis coignetiae in human hepatocarcinoma cells. J Med Food 2009; 12: 967-972 [PMID: 19857058 DO I: 10.1089/jmf.2008.1338]
108. Speciale A, Canali R, Chirafisi J, Saija A, Virgili F, Cimino F. Cyanidin-3-O-glucoside protection against TNF-induced endothelial dysfunction: involvement of nuclear factor-B signaling. J Agric Food Chem 2010; 58: 12048-12054 [PMID: 20958056 DO I: 10.1021/jf1029515]
109. Zhang Y, Lian F, Zhu Y, Xia M, Wang Q, Ling W, Wang XD. Cyanidin-3-O-beta-glucoside inhibits LPS-induced expressionof inflammatory mediators through decreasing IkappaBalpha phosphorylation in THP-1 cells. Inflamm Res 2010; 59: 723-730 [PMID: 20309718 DO I: 10.1007/s00011-010-0183-7]
110. Kaspar KL, Park JS, Brown CR, Mathison BD, Navarre DA, Chew BP. Pigmented potato consumption alters oxidative stress and inflammatory damage in men. J Nutr 2011; 141: 108-111 [PMID: 21106930 DO I: 10.3945/jn.110.128074]
111. Puupponen-Pimiä R, Nohynek L, Ammann S, Oksman-Caldentey KM, Buchert J. Enzyme-assisted processing increases antimicrobial and antioxidant activity of bilberry. J Agric Food Chem 2008; 56: 681-688 [PMID: 18211029 DO I: 10.1021/jf072001h]
112. Kim JM, Kim JS, Yoo H, Choung MG, Sung MK. Effects of black soybean [Glycine max (L.) Merr.] seed coats and its anthocyanidins on colonic inflammation and cell proliferation in vitro and in vivo. J Agric Food Chem 2008; 56: 8427-8433 [PMID: 18710248 DO I: 10.1021/jf801342p]
113. Pinto Mda S, de Carvalho JE, Lajolo FM, Genovese MI, Shetty K. Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria × ananassa Duch.) using in vitro models. J Med Food 2010; 13: 1027-1035 [PMID: 20626254 DO I: 10.1089/jmf.2009.0257]
114. Häkkinen SH, Törrönen AR. Content of flavonols and selected phenolic acids in strawberries and Vaccinium species: influence of cultivar, cultivation site and technique. Food Res Int 2000; 33: 517-524 [DO I: 10.1016/S0963-9969(00)00086-7]
115. Versari A, Biesenbruch S, Barbanti D, Farnell P, Galassi S. Effects of pectolytic enzymes on selected phenolic compounds in strawberry and raspberry juices. Food Res Int 1997; 30: 811-817 [DO I: 10.1016/S0963-9969(98)00050-7]
116. Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutr J 2004; 3: 5 [PMID: 15140261 DO I: 10.1186/1475-2891-3-5]
117. Hannum SM. Potential impact of strawberries on human health: a review of the science. Crit Rev Food Sci Nutr 2004; 44: 1-17 [PMID: 15077879 DO I: 10.1080/10408690490263756]
118. Tanideh N, Akbari Baseri F, Jamshidzadeh A, Ashraf M, Kuhi O, Mehrabani D. The healing effect of strawberry extract on acetic acid-induced ulcerative colitis in rat. World Appl Sci J 2014; 31: 281-288
119. Mazza G, Miniati E. Anthocyanins in fruits, vegetables, and grains: CRC press, 1993
120. Paturi G, Mandimika T, Butts CA, Zhu S, Roy NC, McNabb WC, Ansell J. Influence of dietary blueberry and broccoli on cecal microbiota activity and colon morphology in mdr1a(-/-) mice, a model of inflammatory bowel diseases. Nutrition 2012; 28: 324-330 [PMID: 22113065 DO I: 10.1016/j.nut.2011.07.018]
121. Kalkan Yildirim H. Evaluation of colour parameters and antioxidant activities of fruit wines. Int J Food Sci Nutr 2006; 57: 47-63 [PMID: 16849114 DO I: 10.1080/09637480600655993]
122. Xiao X, Kim J, Sun Q, Kim D, Park CS, Lu TS, Park Y. Preventive effects of cranberry products on experimental colitis induced by dextran sulphate sodium in mice. Food Chem 2015; 167: 438-446 [PMID: 25149009 DO I: 10.1016/j.foodchem.2014.07.006]
123. Sodagari HR, Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Mahmoudi M, Rezaei N. dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2015; 9: 807-820 [PMID: 25586636]
124. Marchi P, Paiotti AP, Artigiani Neto R, Oshima CT, Ribeiro DA. Concentrated grape juice (G8000™) reduces immunoexpression o f iNOS, TNF-a l p h a , COX-2 a n d DNA d ama g e o n 2,4,6-trinitrobenzene sulfonic acid-induced-colitis. Environ Toxicol Pharmacol 2014; 37: 819-827 [PMID: 24637249 DO I: 10.1016/j.etap.2014.02.006]
125. Chu WK, Cheung SC, Lau RA, Benzie IF. 4 Bilberry (Vaccinium myrtillus L.). Lester Packer, PhD 2011: 55
126. Jakesevic M, Xu J, Aaby K, Jeppsson B, Ahrné S, Molin G. Effects of bilberry (Vaccinium myrtillus) in combination with lactic acid bacteria on intestinal oxidative stress induced by ischemiareperfusion in mouse. J Agric Food Chem 2013; 61: 3468-3478 [PMID: 23488931 DO I: 10.1021/jf400203h]
127. Piberger H, Oehme A, Hofmann C, Dreiseitel A, Sand PG, Obermeier F, Schoelmerich J, Schreier P, Krammer G, Rogler G. Bilberries and their anthocyanins ameliorate experimental colitis. Mol Nutr Food Res 2011; 55: 1724-1729 [PMID: 21957076 DO I: 10.1002/mnfr.201100380]
128. Biedermann L, Mwinyi J, Scharl M, Frei P, Zeitz J, Kullak-Ublick GA, Vavricka SR, Fried M, Weber A, Humpf HU, Peschke S, Jetter A, Krammer G, Rogler G. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis-an open pilot study. J Crohns Colitis 2013; 7: 271-279 [PMID: 22883440 DO I: 10.1016/j.crohns.2012.07.010]
129. Minaiyan M, Ghannadi A, Mahzouni P, Jaffari-Shirazi E. Comparative Study of Berberis vulgaris Fruit Extract and Berberine Chloride Effects on Acetic Acid-Induced Colitis in Rats. Iran J Pharm Res 2011; 10: 97-104 [PMID: 24363687]
130. Zhang C, Monk JM, Lu JT, Zarepoor L, Wu W, Liu R, Pauls KP, Wood GA, Robinson L, Tsao R, Power KA. Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis. Br J Nutr 2014; 111: 1549-1563 [PMID: 24521520 DO I: 10.1017/S0007114513004352]
131. Hollman PCH, Arts ICW. Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J Sci Food Agric 2000; 80: 1081-1093 [DO I: 10.1002/(SICI)1097-0010(20000515)80:73.0.CO;2-G]
132. Padalia S, Drabu S, Raheja I, Gupta A, Dhamija M. Multitude potential of wheatgrass juice (Green Blood): An overview. Chron Young Scientists 2010; 1: 23
133. Ben-Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol 2002; 37: 444-449 [PMID: 11989836 DO I: 10.1080/003655202317316088]
134. Márquez-Flores YK, Villegas I, Cárdeno A, Rosillo MÁ, Alarcónde-la-Lastra C. Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways. J Nutr Biochem 2016; 30: 143-152 [PMID: 27012631 DO I: 10.1016/j.jnutbio.2015.12.002]
135. Wang YH, Yu HT, Pu XP, Du GH. Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression. Molecules 2013; 18: 14726-14738 [PMID: 24288000 DO I: 10.3390/molecules181214726]
136. Liu A, Wang W, Fang H, Yang Y, Jiang X, Liu S, Hu J, Hu Q, Dahmen U, dirsch O. Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice. Eur J Pharmacol 2015; 748: 45-53 [PMID: 25533331 DO I: 10.1016/j.ejphar.2014.12.014]
137. Mabalirajan U, Ahmad T, Rehman R, Leishangthem GD, dinda AK, Agrawal A, Ghosh B, Sharma SK. Baicalein reduces airway injury in allergen and IL-13 induced airway inflammation. PLoS One 2013; 8: e62916 [PMID: 23646158 DO I: 10.1371/journal. pone.0062916]
138. Hong T, Jin GB, Cho S, Cyong JC. Evaluation of the antiinflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med 2002; 68: 268-271 [PMID: 11914968 DO I: 10.1055/s-2002-23143]
139. Bayless TM, Harris ML. Inflammatory bowel disease and irritable bowel syndrome. Med Clin North Am 1990; 74: 21-28 [PMID: 2404178 DO I: 10.1016/S0025-7125(16)30583-1]
140. Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, Mizuno M. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-B inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors 2013; 39: 522-533 [PMID: 23460110 DO I: 10.1002/biof.1091]
141. Crespo ME, Gálvez J, Cruz T, Ocete MA, Zarzuelo A. Antiinflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Med 1999; 65: 651-653 [PMID: 10575379 DO I: 10.1055/s-2006-960838]
142. Hui KM, Huen MS, Wang HY, Zheng H, Sigel E, Baur R, Ren H, Li ZW, Wong JT, Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol 2002; 64: 1415-1424 [PMID: 12392823 DO I: 10.1016/S0006-2952(02)01347-3]
143. Nair AR, Joshi B. Oroxindin-A new flavone glucuronide fromOroxylum indicum Vent. Proceedings of the Proceedings of the Indian Academy of Sciences-Chemical Sciences; Springer: 1979: 323-327 [DO I: 10.1007/BF02844710]
144. Wang W, Xia T, Yu X. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-B pathway in vitro. Inflamm Res 2015; 64: 423-431 [PMID: 25917044 DO I: 10.1007/s00011-015-0822-0]
145. Eun SH, Woo JT, Kim DH. Tangeretin Inhibits IL-12 Expression and NF-B Activation in Dendritic Cells and Attenuates Colitis in Mice. Planta Med 2017; 83: 527-533 [PMID: 27806407 DO I: 10.1055/s-0042-119074]
146. Sahu BD, Kumar JM, Sistla R. Fisetin, a dietary flavonoid, ameliorates experimental colitis in mice: Relevance of NF-B signaling. J Nutr Biochem 2016; 28: 171-182 [PMID: 26878795 DO I: 10.1016/j.jnutbio.2015.10.004]
147. Mascaraque C, López-Posadas R, Monte MJ, Romero-Calvo I, Daddaoua A, González M, Martínez-Plata E, Suárez MD, González R, Marín JJ, Zarzuelo A. The small intestinal mucosa acts as a rutin reservoir to extend flavonoid anti-inflammatory activity in experimental ileitis and colitis. J Funct Foods 2015; 13: 117-125 [DO I: 10.1016/j.jff.2014.12.041]
148. Whiting DA. Natural phenolic compounds 1900-2000: a bird's eye view of a century's chemistry. Nat Prod Rep 2001; 18: 583-606 [PMID: 11820759 DO I: 10.1039/b003686m]
149. Hackman RM, Polagruto JA, Zhu QY, Sun B, Fujii H, Keen CL. Flavanols: digestion, absorption and bioactivity. Phytochem Rev 2008; 7: 195 [DO I: 10.1007/s11101-007-9070-4]
150. Thilakarathna SH, Rupasinghe HP. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013; 5: 3367-3387 [PMID: 23989753 DO I: 10.3390/nu5093367]
151. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81: 230S-242S [PMID: 15640486]
152. Stevenson DE, Hurst RD. Polyphenolic phytochemicals-just antioxidants or much more? Cell Mol Life Sci 2007; 64: 2900-2916 [PMID: 17726576 DO I: 10.1007/s00018-007-7237-1]
153. Sato K, Kanazawa A, Ota N, Nakamura T, Fujimoto K. dietary supplementation of catechins and alpha-tocopherol accelerates the healing of trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. J Nutr Sci Vitaminol (Tokyo) 1998; 44: 769-778 [PMID: 10197308 DO I: 10.3177/jnsv.44.769]
154. Contreras TC, Ricciardi E, Cremonini E, Oteiza PI. (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Arch Biochem Biophys 2015; 573: 84-91 [PMID: 25795020 DO I: 10.1016/j.abb.2015.01.024]
155. Kook SH, Choi KC, Cho SW, Cho HK, Lee KD, Lee JC. Catechin-7-O-D-glucopyranoside isolated from the seed of Phaseolus calcaratus Roxburgh ameliorates experimental colitis in rats. Int Immunopharmacol 2015; 29: 521-527 [PMID: 26453508 DO I: 10.1016/j.intimp.2015.10.003]
156. Porath D, Riegger C, Drewe J, Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005; 315: 1172-1180 [PMID: 16123309 DO I: 10.1124/jpet.105.090167]
157. Mochizuki M, Hasegawa N. Protective effect of (-)-epigallocatechin gallate on acute experimental colitis. J Health Sci 2005; 51: 362-364 [DO I: 10.1248/jhs.51.362]
158. Brückner M, Westphal S, Domschke W, Kucharzik T, Lügering A. Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. J Crohns Colitis 2012; 6: 226-235 [PMID: 22325177 DO I: 10.1016/j.crohns.2011.08.012]
159. Yeoh BS, Aguilera Olvera R, Singh V, Xiao X, Kennett MJ, Joe B, Lambert JD, Vijay-Kumar M. Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation. Am J Pathol 2016; 186: 912-926 [PMID: 26968114 DO I: 10.1016/j.ajpath.2015.12.004]
160. Bitzer ZT, Elias RJ , Vijay-Kumar M, Lambert JD. (-)-Epigallocatechin-3-gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss. Mol Nutr Food Res 2016; 60: 2267-2274 [PMID: 27218415 DO I: 10.1002/mnfr.201501042]
161. Chiou YS, Ma NJ, Sang S, Ho CT, Wang YJ, Pan MH. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J Agric Food Chem 2012; 60: 3441-3451 [PMID: 22409325 DO I: 10.1021/jf300441p]
162. Li XL, Cai YQ, Qin H, Wu YJ. Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis. Can J Physiol Pharmacol 2008; 86: 841-849 [PMID: 19088805 DO I: 10.1139/Y08-089]
163. Wang YH, Ge B, Yang XL, Zhai J, Yang LN, Wang XX, Liu X, Shi JC, Wu YJ. Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis. Int Immunopharmacol 2011; 11: 1620-1627 [PMID: 21642017 DO I: 10.1016/j.intimp. 2011.05.024]
164. Wang YH, Yang XL, Wang L, Cui MX, Cai YQ, Li XL, Wu YJ. Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats. Can J Physiol Pharmacol 2010; 88: 888-898 [PMID: 20921975]
165. Li X, Yang X, Cai Y, Qin H, Wang L, Wang Y, Huang Y, Wang X, Yan S, Wang L, Zhao X, Li W, Li S, Chen J, Wu Y. Proanthocyanidins from Grape Seeds Modulate the NF-B Signal Transduction Pathways in Rats with TNBS-Induced Ulcerative Colitis. Molecules 2011; 16: 6721-6731 [PMID: 25134774 DO I: 10.3390/molecules16086721]
166. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003; 139: 209-218 [PMID: 12770926 DO I: 10.1038/sj.bjp.0705241]
167. Maity S, Ukil A, Karmakar S, Datta N, Chaudhuri T, Vedasiromoni JR, Ganguly DK, Das PK. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol 2003; 470: 103-112 [PMID: 12787838 DO I: 10.1016/S0014-2999(03)01760-6]
168. Andújar I, Recio MC, Giner RM, Cienfuegos-Jovellanos E, Laghi S, Muguerza B, Ríos JL. Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells. J Agric Food Chem 2011; 59: 6474-6483 [PMID: 21574661 DO I: 10.1021/jf2008925]
169. Yum HW, Zhong X, Park J, Na HK, Kim N, Lee HS, Surh YJ. Oligonol inhibits dextran sulfate sodium-induced colitis and colonic adenoma formation in mice. Antioxid Redox Signal 2013; 19: 102-114 [PMID: 23394584 DO I: 10.1089/ars.2012.4626]
170. Dryden GW, Lam A, Beatty K, Qazzaz HH, McClain CJ. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis. Inflamm Bowel dis 2013; 19: 1904-1912 [PMID: 23846486 DO I: 10.1097/MIB.0b013e31828f5198]
171. Koláek M, Muchová J, Dvoáková M, Paduchová Z, Ẑitanová I, Ierna I, Országhová Z, Székyová D, Jajcaiová-Zedníková N, Kovács L, uraková Z. Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from Crohn's disease-a pilot study. Free Radic Res 2013; 47: 624-634 [PMID: 23710677 DO I: 10.3109/10715762.2013.807508]
172. Rastegarpanah M, Malekzadeh R, Vahedi H, Mohammadi M, Elahi E, Chaharmahali M, Safarnavadeh T, Abdollahi M. A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis. Chin J Integr Med 2015; 21: 902-906 [PMID: 22528757 DO I: 10.1007/s11655-012-1026-x]